ArticlePsychopharmacology2026
Severity-dependent changes in hippocampal necroptosis markers and neuronal loss in a PTSD-like mouse model: potential involvement of nitric oxide signaling.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-traumatic stress disorder (PTSD) is a psychiatric condition triggered by traumatic events and associated with long-lasting neurobiological alterations, particularly in the hippocampus. Although hippocampal dysfunction plays a central role in PTSD pathophysiology, the molecular mechanisms underlying these alterations-especially those involving nitric oxide (NO) signaling and necroptosis-related pathways-remain incompletely understood.
methodsAdult male Naval Medical Research Institute (NMRI) mice (n = 70) were randomly assigned to seven groups: control, moderate PTSD (MP), MP + L-arginine (MP-Arg), MP + L-NAME (MP-Nam), severe PTSD (SP), SP + L-arginine (SP-Arg), and SP + L-NAME (SP-Nam). PTSD-like stress was induced using a two-day electric foot shock protocol. Behavioral changes were evaluated using the Open Field Test (OFT), Forced Swim Test (FST), and Tail Suspension Test (TST). L-arginine (200 mg/kg) or L-NAME (50 mg/kg) was administered intraperitoneally 60-min before testing to modulate NO signaling. Hippocampal tissue was analyzed for phosphorylated RIP1, RIP3, and MLKL, and neuronal density in the CA1 region was assessed using Nissl staining.
resultsStress exposure was associated with anxiety- and depression-like behaviors, more pronounced in SP than MP mice. Stress was also associated with reduced CA1 neuronal density and increased phosphorylation of RIP1, RIP3, and MLKL. L-arginine treatment was associated with reduced behavioral impairments and partial preservation of CA1 neuronal integrity, whereas L-NAME treatment was associated with more pronounced behavioral and molecular alterations.
conclusionThese findings suggest an association between NO signaling modulation and necroptosis-related molecular changes in the hippocampus under PTSD-like stress conditions. Further studies are required to clarify causal relationships.
Indexed as
Identifiers
42484917What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.